657 related articles for article (PubMed ID: 29460805)
1. Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia.
Gaio P; Verlato G; Daverio M; Cavicchiolo ME; Nardo D; Pasinato A; de Terlizzi F; Baraldi E
Clin Nutr ESPEN; 2018 Feb; 23():234-239. PubMed ID: 29460805
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for metabolic bone disease among preterm infants less than 32 weeks gestation with Bronchopulmonary dysplasia.
Chen W; Zhang Z; Dai S; Xu L
BMC Pediatr; 2021 May; 21(1):235. PubMed ID: 34001070
[TBL] [Abstract][Full Text] [Related]
3. Determinants of Severe Metabolic Bone Disease in Very Low-Birth-Weight Infants with Severe Bronchopulmonary Dysplasia Admitted to a Tertiary Referral Center.
Jensen EA; White AM; Liu P; Yee K; Waber B; Monk HM; Zhang H
Am J Perinatol; 2016 Jan; 33(1):107-13. PubMed ID: 26295968
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
[No Abstract] [Full Text] [Related]
5. Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia.
Yang WC; Chen CY; Chou HC; Hsieh WS; Tsao PN
Pediatr Neonatol; 2015 Dec; 56(6):382-5. PubMed ID: 25997993
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D and bronchopulmonary dysplasia in preterm infants.
Joung KE; Burris HH; Van Marter LJ; McElrath TF; Michael Z; Tabatabai P; Litonjua AA; Weiss ST; Christou H
J Perinatol; 2016 Oct; 36(10):878-82. PubMed ID: 27467562
[TBL] [Abstract][Full Text] [Related]
7. Bronchopulmonary dysplasia in very preterm infants: Outcome up to preschool age, in a single center of Austria.
Reiterer F; Scheuchenegger A; Resch B; Maurer-Fellbaum U; Avian A; Urlesberger B
Pediatr Int; 2019 Apr; 61(4):381-387. PubMed ID: 30793436
[TBL] [Abstract][Full Text] [Related]
8. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
Chen X; Li H; Qiu X; Yang C; Walther FJ
BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral content and growth in very-low-birth-weight premature infants. Does bronchopulmonary dysplasia make a difference?
Greer FR; McCormick A
Am J Dis Child; 1987 Feb; 141(2):179-83. PubMed ID: 3812385
[TBL] [Abstract][Full Text] [Related]
10. The Utility of Comprehensive Metabolic Panel Tests for the Prediction of Bronchopulmonary Dysplasia in Extremely Premature Infants.
Chen X; Lin B; Xiong X; Sun P; Kong Y; Yang C
Dis Markers; 2019; 2019():5681954. PubMed ID: 31772691
[TBL] [Abstract][Full Text] [Related]
11. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
[TBL] [Abstract][Full Text] [Related]
12. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
13. [A retrospective cohort study on the correlation between early energy management and bronchopulmonary dysplasia in premature infants].
Lin Q; Mu YJ; Song Y; Wang H
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):239-244. PubMed ID: 38378285
[No Abstract] [Full Text] [Related]
14. [Association between serum 25(OH)D levels at birth and bronchopulmonary dysplasia in preterm infants].
Yu RQ; Chen DZ; Zhou Q; Wang M; Mei YZ; Jiang SY
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Oct; 19(10):1051-1055. PubMed ID: 29046199
[TBL] [Abstract][Full Text] [Related]
15. Don't Forget the Bones: Incidence and Risk Factors of Metabolic Bone Disease in a Cohort of Preterm Infants.
Perrone M; Casirati A; Stagi S; Amato O; Piemontese P; Liotto N; Orsi A; Menis C; Pesenti N; Tabasso C; Roggero P; Mosca F
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142579
[TBL] [Abstract][Full Text] [Related]
16. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.
Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R
Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701
[TBL] [Abstract][Full Text] [Related]
17. Biochemical Screening for Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.
Montgomery AM; Bazzy-Asaad A; Asnes JD; Bizzarro MJ; Ehrenkranz RA; Weismann CG
Neonatology; 2016; 109(3):190-4. PubMed ID: 26780635
[TBL] [Abstract][Full Text] [Related]
18. Relation between serum insulinlike growth factor-1, insulinlike growth factor binding protein-2, and insulinlike growth factor binding protein-3 and nutritional intake in premature infants with bronchopulmonary dysplasia.
Price WA; Lee E; Maynor A; Stiles AD; Clemmons DR
J Pediatr Gastroenterol Nutr; 2001 May; 32(5):542-9. PubMed ID: 11429514
[TBL] [Abstract][Full Text] [Related]
19. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants.
Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I
Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654
[TBL] [Abstract][Full Text] [Related]
20. Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates.
Kavurt S; Demirel N; Bas AY; Ulubas Isık D; Ozcan B; Aydemir O
J Matern Fetal Neonatal Med; 2017 Apr; 30(7):864-869. PubMed ID: 27268203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
